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ASSTRACT 
Pathophysiology of I ndotoxin 
Microvascular Dvslunction, 
And the Roles ot' VFGF and Nitric Oxide (NO) (April 2001) 
Mark Andrev Naftanel 
Department of' Medical Physiology 
Texas ARM L'niversitv System Health Science Center 
Fellov s Advisor Dr Janet I, Parker 
Department ol' Medical Physiology 
Vascular endothelial growth factor (VFGF) eltcits nitric oxide (NO)-dependent 
vasodilation and plays major roles in angiogenesis and wound healing Although bacterial 
endotoxin (LPS) has been shov n to alter endothelial NO synthase (ccNOS)/NO regulation. 
interactive elfects of LPS and NO-dependent responses to VFGF have not been examined 
tJI'c compared microvascular endothelium-dependent relaxation (EDR) to VFGF' ' 
(10 '"- 3x10rnM) in mesenteric microvessels (--150 pm) isolated from comrol (sterile 
saline-treated) and endotoxemic (J. , cr&A LPS, 0 m~~'kg i p . 16 hrs) guinea pigs 
Specialized microvessel myographs and isometric techniques were used to study EDR to 
VEGF tollosving pre-contraction ot'vessels with endothelin-I (- ECsa) Mictovcsscls 
isolated lrom control animals, but not LPS-treated animals, exhibited signiticant 
concentration-dependent FDR to VEGF. vasorelaxation ('/o endothelin precontraction) at 
3x10 M VFGF averaged 63s 17'/o and II It 9 9"o, respectively. Furthermore, exposure 
to the NO synthase inhtbitor L-NMMA (100PM) significantly blocked vasotelaxation to 
VKGF ( ''-3x10 ' ' M) of control microvessels, but produced no effect on microvessels lrom 
LPS-treated animals; relaxation at 10 " Xt VEGF averaged 4 4~ 18'/o and -1 1+ 1 1 . 'o, 
respectively Thus, these data indicate that ur me cndotoxemia impairs NO-depcndent rn 
vrrro microvascular relaxation to VEGF Since NO plays a major role in VEGF-stimulated 
vasodilation, permeabilitv, proliferation, and anuiovenesis. these data mav implicate LPS- 
induced impairment ot' VEGF-stimulated NO production in the endothelial 
pathophysiolouy of shock/sepsis 
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I!y(TRODI'CTIO;»I 
Septic Shock 
Septic shock (also known as endotoxic shock) is a major cause ot illness and death 
among hospitalized patients Despite extensive research, septic shock still results in over 
100 000 deaths annually, making it the leading cause of death in surgical intensive care 
units ( I) Research in the last tev, decades has increased the understanding of septic 
shock's underlying pathophysiological mechanisms and improved the treatment ol'septic 
patients, but the mortality rate due to septic shock remains alarming»ly high (2) 1 herefore, 
it continues to be an area ol intense research v ith profound clinical implications 
In the early stages of'sepsis and shock, patients shov general signs ofbacterial 
infection (e g fever; increased circulation) As the intection progresses, plasma is lost into 
infected tissues through "!caky" capillary v, alls, reducing overall blood pressure At a 
certain point. the deterioration of circulation becomes progressive lil e all other types of 
shock, in which the cardiovascular system itself — heart, blood vessels, vasomotor system— 
begins to break doivn. so that the shock state becomes progressively v«orse (3) Shock 
ultimately results in hypotension (low blood pressuic) associated with indications of poor 
tissue perhision such as decreased urine production, reduced skin perlusion, and alteration 
in mental alertnes~ (0) Low blood pressure and the concomitant insuAicicnt blood flov 
cause various organ dy stunctions, which include reduced alertness. hypoxemia. increased 
airway resistance. reduced protein synthesis, increased bilirubin levels, and impaired 
glucose metabolism (5) 
This thesis folloivs the stvle and format of Shor l» 
Vascular dysfunction during septic shock is characterized by a heterogeneous 
mixture of peripheral vasodilation and vasoconstriction in ditTerent organs resulting in 
decreased systemic vascular resistance, regional blood flow insufficiency, and tissue 
ischcmia (6. 7) ln addition to its ellects on vascular resistance, it is now recognized that 
septic shock can also lead to myocardial depression This is more difficult to diagnose 
because cardiac output (product of heart rate and stroke s olurne) is usually high or normal 
in septic patients, particularly in the early stages The observed increased cardiac output is 
a result of the neurohumoral compensatory mechanisms (i e tachycardia) seen in sepsis, 
these mechanisms tend to mask the decreased contractile function caused by the depression 
of' cardiac muscle (0) 
I. ipopolysn«charide (LPS) 
A major mediator of septic shock is bacterial lipopolysaccharide (I. PS), also knov;n 
as endotoxin I'schetvchru err(i (I;. culi) is the inost common causative agent in septic 
shock, and the I;. celt cell avail component LPS is believed to mediate many 
pathophysiologic eAects as well as elicit the release of numerous secondary mediators. 
Endotoxins include a sariety of macromolecules with an approximate molecular v eight of 
200, 000 that are integral membrane proteins of Gram-negative bacteria cell walls. Protein 
and LPS molecules are released during cell growth and cel! Ivsis, and these materials 
provide the components required to synthesize endotoxin (g) 
Bacterial endotovins and their dov, nstrcam mediators have profound physiological 
etfects (9) In our current research, v c focus on endotoxin's role m septic shock as it 
rclatcs to its effects on the v asodifators VLGF and nitric oxide 
Nitric Oxide (NO) 
Before proceeding, to a discussion ol nitric oxide, it is impottant to describe the 
endothelium and hovv it relates to vascular relaxation All blood vessels, including arteries, 
arterioles, capillaries, venules, and veins. aie lined v, ith a single layer of endothelial cells 
These cells f'orm a barrier between the blood and interstitial fluid, allowing the exchange of 
nutrients and waste products bct»een the blood and tissues (10) In addition, it is now 
clear that endothelial cells play an important role in the regulation of blood flow 
Endothclial cells are especially important in the current research because many 
vasorelaxation cfTects are mediated by the endothelium 
Nitnc oxide is a naturally occurring vasodilator, and because of its vascular 
relaxation effects, it is also known as endothehal-derived relaxing factor (EORMS) Small 
amounts of NO are critical t'or maintaining appropriate vascular tone, and it has been 
reported to protect against pathological vasoconstriction and organ damage during 
circulatory disorders (11) Under normal physiological conditions, NO is generated trom 
L-arginine by the calcium/calmodu)in-dependent enzyme, constitutive NO synthasc 
(ecNOS), in endothclial cells The NO difTuses into adjacent vascular smooth muscle cells 
and activates guany late cvclase, producing cGMP This in turn elicits vascular relaxation 
bv activating a cGMP-dependent protein kinasc»ithin smooth muscle (12) 
Nitric oxide production can be increased by numerous normal physiological 
tactors. one of which is shear stress Thc rapid floiv ofblood through arterioles increases 
shear stress on the endothelial cells that line the vessels, inducing an increased release of 
nitric oxide The NO then diffuses into the vascular smooth muscle. producing 
vasodilation (13) 
During sepsis, ~arious mediators such as endotoxin and cytohines stimulate the 
induction of another isolorm of the enzyme. inducible NO synthase (iNOS) This calcium- 
independent isoenzyme produces abnormally large amounts of NO, resulting in excessive 
vasodilation that contributes to thc h) potension found in septic shocl At the same time. 
various vasoconstricting substances including thromboxane and endothelins are also 
released As a result there is interactive and compte~ competition betv een the antag- 
onistic efl'ects of vasodilation and vasoconstriction elicited by sepsis and underlying 
mediators 
N 
' 
monomethvl-L-arginine (L-NMMA) is a structural analogue ol l, -arginine L- C 
NMMA thus serves as a competitive inhibitor ot both NO synthase iso(orms, blocking NO 
production ( la) Therefore, we will use this NO inhibitor to evaluate NO-mediatcd effects 
of VEOF Figure 1 below is an illustration shov'ing how L-NMMA acts to inhibit NO 
synthase, resulting in a decrease in NO production and decreased vascular relaxation 
responses to receptor agonists 
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Figure 1 Endothelium-mediated vascular relaxation to agonists: 
inhibition by L-NMMA. 
Acetylcholine (ACh) 
Acctvlcholinc is a common neurotransmitter that activates nicotinic and muscarinic 
cholingergic receptors throughout the body In thc microvascular circulation, ACh acts on 
muscarinic receptors ol'endothelial cells to increase production of NO (by increasing the 
activity of NOS), thus causing vascular smooth muscle relaxation ()5). Due to its vvcll- 
documented vasodilation el'feet, ACh o(Icn serves as the gold standard for comparison with 
other endothelium-mediated vascular relaxation agonists Figure 2 depicts the binding of 
ACh (or other receptor agonist) to endothelial cell receptors, v hich increases the levels of 
NO and results in vasodilation. 
VKGF (Vascular endothelial growth factor) 
Vascular endothelial growth factor (VEGF) is an endothelium-specific 
glycoprotein that enhances endothclial cell growth, mcrcases vascular permeability, and 
stimulates vasodilation (I 6) Recent research has shown that VI=. Crp exerts its effects 
through receptor-dependent pathsvays involving NO synthase (l7, IS) With increased 
NOS activity, the levels ol NO rise and the usual endothelium-mediated relaxation of 
vascular smooth muscle is seen Figure 3 elucidates several of the VEGF pathways, we 
will be investigating& the path~ay that goes from VEGF receptor binding through ecNOS to 
vascular smooth muscle relaxation VEGF has also been shov, n (. o play a role in the 
pathogenesis ot septic shock, as LPS augments VECiF expression and secretion in rat 
coronary vessels ( l9) 
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Figure 2. Endothelium-mediated vascular relaxation to agonists. 
(from J L Parker, modified from ll Granger and colleagues) 
VEGF SIGNALING IN ENDOTHELIUM 
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Currertt Status of Research 
'fhe last decade has u itnessed an esplosion of research and new knowledge in the 
area ot'septic shock The roles ot' VFGF and NO are becoming more clear, but much 
remains to be learned The aim ot this research is to elucidate the role ol'VEGF in septic 
shock, specitically as it relates to microvascular function The large vessels have been 
thoroughly studied. but it is unclear whether the microvessels operate in a similar manner 
Since the microcirculation is the domtnant determinant ot overall blood pressure, it is 
)mportant to insestigate thc elfects that septic shock have on VEGF and NO and their 
interactions at this les el 
MATERIALS AND METHODS 
For this research project. I emploved methods used by Dr Parker's lab. These 
methods include the techmques tor inducing ui ivi o endotoxemia in guinea pigs and ni 
wrro techniques tor measuring intrinsic contraction-relaxation characteristics of isolated 
blood vessels (20) These procedures are summarized below 
Subjects 
Hartley-strain male albino guinea pigs, weighing between 250 and 400 g. werc 
used as subjects in this studv The animals v ere kept at room temperature (between 22' 
and 24'" C), a 12-hour light-darl' cycle was maintained by artificial light, and experiments 
were timed so that blood vessel isolation began between 12 00 and 2 00rxi All animal 
procedures were reviewed and approved by the University Laboratory Animal Care 
Committee (L'LACC) of Texas AkM Lniversitv College Station. TX 
Kndotoxemia Model 
Gram-negative endotoxemia v, as produced bv intraperitoneal injection of 4 mp~kg 
purified Fx co(r endotoxin fhis procedure has been shown to consistently elicit a state of 
circulatory shock characterized hv central nervous system depression, hypothermia, = 20';0 
mortality, early compensatory hyperpnea, minimal changes in arterial blood gases, and 
signilicant decreases in systolic and diastolic blood pressures by 16-18 hours aller 
injection of endotoxm (21, 22) In the current study, blood vessels v ere isolated 16-18 
hours after the injection of either cndotoxin or an equal volume of sterile isotonic saline 
solution (control vessels) Four guinea pigs vvere used during each trial (two control 
vessels. two endotoxin-exposed vesselsl 
Vessel Collection and Preparation 
Guinea pigs were anesthetized with sodium pentobarbital (65 my~'kg) prior to 
decapitation, and the mesenteric artenes found in the abdominal cavity were quickly 
removed and placed in ice-cold bicarbonate-bu(Tered solution Vessels were cleaned of 
adipose and connective tissue, and then cut into rings with a~ial lengths of approxtmatclv 
! 5 mm Average vessel dimensions used in this studv are presented in I'able I below 
Table ! Mesenteric arteries vessel dimensions. 
Outer Inner Wall Axial 1 
Control 14 248et0 1 162z9 2 39+1 4 1. 52+. 01 
( 
LPS t4 263e6 3 174&5 5 36et 2 1 52' 01 I 
Values are means ~ SL in pm; n. total number of vessels 
studied in each & roup 
The mesenteric rings were mounted on tsvo 2(t-)tm tunusten wires passed through 
the vessel lumen (Figure 4) (23) One tvire svas attached to a force transducer, and the 
other was attached to a micrometer mounted on the transducer This setup enabled the 
vascular rings to bc stretched by known increments while isometric force was measured 
The mounted vessels were then lowered into individual 20-mL tissue baths containing 
Krcbs' bicarbonate solution Figurc 5 pictures the overall myograph setup (23) 
R. 
i'igure 4. Dissection and mounting of mesenteric arteries. 
(trom Mulvany and Halpern. )977) 
Figure 5 View of microvessel mgograph. 
(from Mulvang and Halpern, l 977) 
Solutions and Drugs 
The Krebs bicarbonate butfer contained (in mM) 131 5 NaCI. 5 0 KCI, I 2 
NaHiPOq, I 2 MgCli, 2 5 CaCI. , 25 0 NaHCOi, and 11 2 glucose This solution v as 
aerated with 95 to 02-5 ''o C02 (pH 7 35) and was maintained at 37'C In designated 
solutions, the KCI concentration was increased in a substituted manner Acetylcholine, L- 
NMMA, and endothelin were purchased trom Sigma Chemical Company. while VLGE 
was obtained from RA, 13 Systems (Minneapolis MN) Endotoxin was purchased as 
lipopolysaccharide W, 0127 iB8 and was prepared in sterile isotonic saline solution 
Concentration-Response Curves 
After in vitro stabilization and a rapid transient stretching ot each vessel three 
times, each mesenteric vessel v, as systematically stretched to the optimum of its iength- 
active tension relation (L„, „, ) We used a modified length-tension curve, with!. „, „, equal to 
95 o of Liij(i (described below) This protocol was used because previous studies by Parker 
and colleagues have shown that guinea pig microvessels are optimally stretched at 95 o ol 
the determined Liiiii value In order to determine each vessel's Lugs the vessels weie 
started in their relaxed state (absence of stretch) The internal circumference (L), measured 
in pm, was calculated using the formula 
L — 21 ~ 102 83 
where f is the distance between svires as measured bv the micrometer. Then a known 
amount of passive stretch was applied to each vessel, and the corresponding increase in 
passive wall tension (mNewtonsimm) was determined from thc myograph recorder 
printout The amount ol'stretch was incieased until the plot of passive wall tension 
l2 
intersected the calculated standardized plot of v, all tension at 100 mm HG (I. ii&v) The 
intersection of these two lines uas taken as Livii, and this value ivas multiplied by 0 95 to 
generate I, „AII subsequent concentration response studies for vasodilators were 
perlortned v ith the vessels at L„, , „ In tvio of the tour vessels in each trial, 100 pL L- 
Nlv(MA was added to the circulating baths to investigate the eflects ot inhibiting the nitric 
oxide svnthase 
Prior to initiating the dose response curves, g0 mM K (substituted) v'as added to 
provide a maximum contraction for each vessel We compared this value with the level of 
contraction elicited by endothelin. which was about 50'!o of the maximum K -induced 
contraction AIIer restabilizing the vessels. endothelin (0 nM — 7nivl) was added to pre- 
constrict the vessels 1 he contractile response was allowed to plateau, at which time the 
VEGF concentration-response curve v as performed in a cumulative manner The 
concentrations of VEGF used were IO "M. 10 " M, 10' M, 10" M, 3 x 10" M, doses 
v ere administered approximately eight minutes apart Following the maximal VEGF 
response, all baths were rinsed several times with Krebs' bicarbonate solution Endothelin 
v'as added to re-constrict the vessels. ader v, hich the acetylcholine concentration-response 
was administered The concentrations of ACh used were 10" M, 10 M, 10' M, 10' M, 
and 10 5'I, v, ith each dose given atter the relaxation response had plateaued (withm five -1 
minutes) Relaxation responses are presented as a percentage ('/o relaxation) of the 
endothelin precontraction 
Data Analysis and Statistics 
All ot'the traces were hand-scored to generate numerical data The SAS statistical 
software was utilized to analyze and statistically compare our data. We performed a split- 
plot AVOVA to determine whether there was a significant difl'erence betv een the shocl 
and control vessels Fisher's I. SD mean separationtest was used to compare differences 
between mean responses to indiv idual doses Data in graphs is presented as mean +/- 
standard error 
For acetylcholine responses (absence of L-ViMMA), mv data was combined with 
data previously collected m Dr Parker's lab and results analyzed using pooled data from 
both groups The losvest ACh dose used in the previous work was 10 ' M. whereas my 
starting dose was 10" M As a result, the n value for the 10 M dose is four and the n 
value for all other doses is eight All of the data involv ing I. -lviiXIMA was collected during 
the present study 
la 
RES(. 'LTS 
Acetylcholine 
Acetylcholine produced significant relaxation responses ol mescnter'ic microvcssels 
isolated from both control and LPS- treated (shock) guinea pirrs However, acetylcholine 
relaxation was signilicantly impaired in mesenteric rnicrovessels from LPS-treated 
animals 1'igure 6 shows the relaxation responses to acetylcholine in the absence of L- 
EMMA treatment, presented as a percentage relaxation of the endothelin precontraction 
The graph sho~s that there was a significant dil ference (p& 01) between the shock and 
control i essels' response to the three lowest doses ot'A('h (10 ' M, 10 ' M, and 10' M) 
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Figure 6 ACh dose-response curve, no pre-treatment. 
Guinea pig mesenteric arteries. 16 hrs LPS 
fs 
Inhibition of NO synthase using L-xfMMA decreased relaxation responses to 
acetylcholine, particulally at lower concentrations 110 
' M) These results are summarized 
in Figure 7 
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Figure 7 ACh dose-response curve, 100 pL L-NMMA. 
Guinea pig mesenteric arteries, ! te hrs I. PS 
l6 
VKGF 
These results were the main tocus of this research project We ran seven separate 
trials, so the n value is seven f' or all groups except the no pre-treatment control group 
(which has an n value of six) As seen in Figure 8, VEGF-mediated relaxation was 
sig&nificantly inhibited in mesenteric microvessels lsolatcd trom I, PS-treated (shock) 
animals as compared to mlcrovessels from control animals The difference between the 
overall concentration-response curves was siynificant (p '- 01), and all but the lowest dose 
of VEGF were signitlcantly dit'terent between the shock and control vessels 1 he 
relaxation response (mean 4 I- standard error) at the maximum VEGF administration 
(8 x 10 M) was 8 ) + 9 9"0 and (33 0 1 17 1'rn fOr the shocl' and control vessels, 
respectivelv 
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Figure 8 VEGF dose-response curve, no pre-treatment. 
Guinea piy mesentcric arteries 16 hrs LPS 
17 
Upon administration of L-NMIk(A, the relaxation response to VFGF was 
significantly reduced in the control vessels (Figuixc 9) Hov, ever, since VFGI relaxation 
was already minimal in the shock group, L-NMMA produced no further inhibition of the 
VEGF response Figure 9 shows that the onlv signilicant difference between relaxation 
responses in shock and control vessels v, as at the highest dose of VEGF (3 x 10 " M) 
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Figure 9 VEGF dose-response curve, 100 pL L-(X(MILIA. 
Guinea pig mesenteric arteries. 16 hrs LPS 
CONCLL'S1ON 
Acetylcholine 
Mesenteric microvessels isolated from LPS-treated (shock) guinea pigs showed 
significantly less relaxation to the three lowest doses of ACh as compared to control 
vessels However. maximal relaxation response was not si& nilicantly different betv een the 
two groups at the highest concentrations of'ACh Thus, although microvessels from LPS- 
treated animals exhibited decreased sensitivity to acetvlcholine. maximal relaxation was 
unafTected Decreased relaxation to acetylcholine at lower concentrations (decreased 
sensitis ity) suggests that LPS treatment may impair endothclial function and NO 
production in response to acetvlcholine This conclusion supports previous reports by 
Pari er and collcagucs of impaired endothelial function and decreased NO production in 
aorta isolated from LPS-treated guinea pigs (20, 24) One possible explanation for the 
unaltered maximal response is that the higher concentrations ot'ACh managed to increase 
the levels of nitric oxide to such an extent that it overcame the shock-induced impairment 
of vasorelaxation 
The NO synthase blocker L-NMMA inhibited acetylcholine responses of both 
shock and control groups and revei sed the shock-induced iinpairment at the lower 
acetylcholine concentrations tlowever, the lour highest doses of ACh elicited 
signilicantly dilTerent relaxation responses in the shock and control vessels These results 
emphasize the point that an ACh-mediated increase in NO production is not the only 
mechanism resulting in vasodilation 
VF. GF 
Our results indicate that u& wi &i endotoxemia impairs NO-dependent n& iv&r&i 
relaxation to VEGF. Indeed, mesenteric microvessels isolated from control animals 
exhibited significant ('-' 60"«) relaxation of endothelin precontractions. whereas 
microvessels isolated from LPS-treated animals exhibited minimal relaxation to VEGF 
These results support other lines ol evidence that shov, agonist-stimulated nitric oxide 
production is impaired in septic shock (20, 24) To our knowledge, no other study has 
evaluated etfects of I PS upon microvasculai responses to VFGF Our results are 
particularly significant because the microvasculaturc is primarily responsible tbr vascular 
tone and thus is the major determinant of'svstemic blood pressure Also. since NO plavs a 
major role in VEGF-stimulated dilation, permeability, proliferation, and angiogenesis, 
these data mav implicate impaired VEGF-stimulated NO production in the 
pathophysiology of shockisepsis 
Our data using the inhibitor of NO synthase provided functional data suggesting 
that the mechanism underlying LPS-induccd impaired VEGF responsiveness involves 
decreased NO synthesis/'production The next logical step in this line ol' study is to 
investigate the direct production of nitric oxide upon administration of VEGF Dr 
Parker's lab has recently acquired a sophisticated nitric oxide analyzer that will permit the 
direct on-line measurement ol nitric oxide via chemiluminescence techniques However, 
the operation of this equipment is quite comple~, and it has required some trial and error to 
perl'ect the procedure After these initial problems are worked through, we will be able to 
take cultured endothelial cells or isolated microvessels and directly measure the amount ot' 
nitric oxide given olf by these cells Our current study indicates that VFGF exerts its 
vasodilation etTects via a nitric oxide pathway and that exposure to Lpg inhibits this 
pathv, ay I'he added line ol'ei idence «ith direct measures of UO and cultured cells would 
serve to support this finding 
Throughout the project, seveial minor probleins arose which had to be dealt with 
First of all, the very nature of VEGF and its complex intracellular pathways result in a 
slow-acting vascular smooth muscle relaxation response VEGF utilizes a tyrosinc kinase 
second messenger system, so vasodilation effects are not seen immediately On the other 
hand. acetvlcholine acts much more quickly on the x ascular smooth muscle, so its el'lects 
are more readily seen Another complication in this study was the possibility that the 
cndothelin continued to vasoconstrict the vessels after the dose-response cui ve had been 
started l paid special attention to wait for the vessels to reach a steady level of 
constriction, but some of the vessels never completely leveled ofT Therelore, it is possible 
that some of the vasodilation responses to VEGF and/or ACh may have been masked by 
the continued endothelin-mediated vasoconstriction This, along with the slow-acting 
nature ol VEGF, would have resulted in an under-estimation of the actual relaxation 
caused bv VEGF andior ACh Finally, we had one very odd response to VEGF 
admmistration in one of our trials On thc I 'Si00 trial, thc administration of VECiF was 
l'ollowed by a distinct contraction response, and even the highest doses of VLGF did not 
elicit any relaxation These results did not match our other data, but we could not think ol 
a good reason for why this occurred As a result, we included this data in the statistical 
analyses and we still had signiticant difterences betv;een the shocl and control groups. 
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